Products

Izovac IB

An aid in the prevention of decreased egg production due to Infectious Bronchitis (IB) virus infection.

Category:

Indication

An aid in the prevention of decreased egg production due to Infectious Bronchitis (IB) virus infection.

Presentation

1000 doses of inactivated Infectious Bronchitis virus strain Massachusetts M41 in oil emulsion per 500 ml bottle.

Vaccination program

There are two standard IB vaccination programs.

Program 1. Two attenuated live primer vaccinations Poulvac® Bron Vic S plus one inactivated booster vaccination Izovac IB.

Program 2. Two attenuated live primer vaccinations Poulvac® Bron Vic S followed by a live booster vaccination Poulvac® Bron Vic S repeated at intervals of 8 weeks.

Izovac IB program

Izovac IB program

Vaccine administration

At 16 to 20 weeks of age administer 0.5 ml Izovac IB by intramuscular injection.

There should be an interval of four weeks between the final attenuated live primer vaccination and administration of the inactivated booster Izovac IB vaccine.

Precautions

Store refrigerated at 2 to 8°C. Do not allow to freeze.

Allow the vaccine to reach room temperature (22°C) before use.

Shake well before and during use. After opening use within 10 hours.

In case of accidental human injection seek immediate medical attention.

Vaccinate healthy birds only.

See Izovac IB package insert for detailed Directions for Use.

Izovac IB registered pursuant to the ACVM Act 1997, No. A11318. See www.foodsafety.govt.nz for registration conditions.

Further Information

Disease Information Sheet
Infectious Bronchitis (IB)

Administration Information Sheet
Intramuscular injection

Safety Data Sheet
Izovac IB Safety Data Sheet

Product Information Sheet
Izovac IB

Type

Breeder, Layer

Region

New Zealand, South Pacific